𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of synchronous lung tumors in patients presenting with squamous cell carcinoma of the head and neck

✍ Scribed by Samit K. Ghosh; Nicholas J. Roland; Aman Kumar; Sankalap Tandon; Jeffrey L. Lancaster; Shaun R. Jackson; Andrew Jones; Huw Lewis Jones; Rebecca Hanlon; Terry M. Jones

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
157 KB
Volume
31
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

Screening for synchronous pulmonary tumors in patients presenting with squamous cell carcinoma of the head and neck (SCCHN) is important, because detection may alter subsequent management.

Methods.

We conducted a retrospective review, comparing effectiveness of pulmonary screening using thoracic CT or chest X‐ray, in 1882 patients presenting with SCCHN.

Results.

The overall rate of synchronous pulmonary tumors was 4.3%. The number needed to scan, ie, the number of thoracic CTs required to detect 1 pulmonary tumor, is reported for recurrent primary tumors, primary disease load (T and N classification), and individual primary sites. The incidence of pulmonary metastases is related to locoregional disease load while the incidence of bronchogenic carcinoma is sporadic.

Conclusion.

Although it is possible to propose a pragmatic screening protocol for pulmonary metastases, this is not possible for bronchogenic carcinomas. Therefore, we recommend that thoracic CT is used in all cases to screen for coexistent pulmonary pathology. Β© 2009 Wiley Periodicals, Inc. Head Neck, 2009

πŸ“œ SIMILAR VOLUMES

Efficacy of neck treatment in patients w
Efficacy of neck treatment in patients with head and neck squamous cell carcinoma
✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the

18F-FDG-PET/CT versus panendoscopy for t
18F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma
✍ Stephan K. Haerle; Klaus Strobel; Thomas F. Hany; Daniel Sidler; Sandro J. Stoec πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 1 views

## Abstract ## Background. This study assesses the additional value of ^18^F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography/CT (^18^F‐FDG‐PET/CT) with respect to synchronous primaries in patients undergoing panendoscopy for staging of head and neck squamous cell carcinoma. ## Methods. In

Immunoglobulin allotypes in patients wit
Immunoglobulin allotypes in patients with squamous cell carcinoma of the head and neck
✍ Theodorus Ockhuizen; Janardan P. Pandey; Robert W. Veltri; Myron Arlen; H. Hugh πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 403 KB πŸ‘ 2 views

Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant

Detection of MAGE-4 protein in sera of p
Detection of MAGE-4 protein in sera of patients with head-and-neck squamous-cell carcinoma
✍ Osamu Iwamoto; Yumiko Nagao; Shigeki Shichijo; Masao Eura; Tadamitsu Kameyama; K πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 123 KB πŸ‘ 2 views

The MAGE-4 gene, a member of the MAGE gene family, is expressed in various cancers, including head-and-neck squamous-cell carcinomas (HN-SCC), but is not expressed in any normal tissues except for the testis and placenta. The aim of this study was to determine whether serum MAGE-4 protein is a usefu